(Q51968519)
Statements
Immunotherapy with chimeric NKG2D receptors leads to long-term tumor-free survival and development of host antitumor immunity in murine ovarian cancer. (English)
1 reference
Amorette Barber
1 reference
Tong Zhang
1 reference
Charles L Sentman
1 reference
1 January 2008
1 reference
180
1 reference
1
1 reference
72-78
1 reference